About Dual AAV
Dual AAV vectors split your gene into two vectors that under in-vivo homologous recombination, reforms to produce a full gene product. These are used when payloads >4.7kb are required.
Dual AAV vector controls contain two AAV vectors, with each vector carrying half of a GFP reporter gene. When recombined, a functional GFP is formed, allowing quick visual read-out.
Your team can use dual AAV vector controls to de-risk projects, for proof-of-principle studies, and to optimize parameters before moving into larger, more complex experiments. These controls are available in a wide range of promoters for tissue targeting.
Features
· >95% Purity
· Low endotoxin (<0.3 EU/ml)
· Whole plasmid sequencing
· Dedicated technical support
Benefits
· Efficient delivery of large genes >4.7kb
· >95% Purity
· Low endotoxin (<0.3 EU/ml)
· Whole plasmid sequencing
· Dedicated technical support
Benefits
· Efficient delivery of large genes >4.7kb
AAV-h-ARAF-shRNA
Cat No: shAAV-201249
Availability: 4-5 weeks
AAV-h-ARAP1-shRNA
Cat No: shAAV-201252
Availability: 4-5 weeks
AAV-h-ARAP2-shRNA
Cat No: shAAV-201253
Availability: 6-8 weeks
AAV-h-ARC-shRNA
Cat No: shAAV-201254
Availability: 6-8 weeks
AAV-h-ARCN1-shRNA
Cat No: shAAV-201256
Availability: 4-5 weeks
AAV-h-ARD1A-shRNA
Cat No: shAAV-201259
Availability: 4-5 weeks
AAV-h-ARD1B-shRNA
Cat No: shAAV-201261
Availability: 6-8 weeks
AAV-h-AREG-shRNA
Cat No: shAAV-201262
Availability: 6-8 weeks
AAV-h-ARF1-shRNA
Cat No: shAAV-201265
Availability: 4-5 weeks
AAV-h-ARF3-shRNA
Cat No: shAAV-201268
Availability: 4-5 weeks
AAV-h-ARF4-shRNA
Cat No: shAAV-201272
Availability: 4-5 weeks
AAV-h-ARF5-shRNA
Cat No: shAAV-201276
Availability: 4-5 weeks
